Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Summit Therapeutics (SMMT) Long-Term Debt Issuances (2016 - 2022)

Historic Long-Term Debt Issuances for Summit Therapeutics (SMMT) over the last 3 years, with Q4 2022 value amounting to $520.0 million.

  • Summit Therapeutics' Long-Term Debt Issuances changed N/A to $520.0 million in Q4 2022 from the same period last year, while for Sep 2023 it was $520.0 million, marking a year-over-year increase of 198000.0%. This contributed to the annual value of $545.0 million for FY2022, which is 39545.45% up from last year.
  • Per Summit Therapeutics' latest filing, its Long-Term Debt Issuances stood at $520.0 million for Q4 2022.
  • Summit Therapeutics' 5-year Long-Term Debt Issuances high stood at $520.0 million for Q4 2022, and its period low was $25.0 million during Q1 2022.